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OBJECTIVE — Impaired muscular mitochondrial function is related to common insulin
resistance in type 2 diabetes. Mitochondrial diseases frequently lead to diabetes, which is mostly
attributed to defective -cell mitochondria and secretion.
RESEARCH DESIGN AND METHODS — We assessed muscular mitochondrial func-
tion and lipid deposition in liver (hepatocellular lipids [HCLs]) and muscle (intramyocellular
lipids [IMCLs]) using
31P/
1H magnetic resonance spectroscopy and insulin sensitivity and en-
dogenousglucoseproduction(EGP)usinghyperinsulinemic-euglycemicclampscombinedwith
isotopictracerdilutioninonefemalepatientsufferingfromMELAS(myopathy,encephalopathy,
lactic acidosis, and stroke-like episodes) syndrome and in six control subjects.
RESULTS — The MELAS patient showed impaired insulin sensitivity (4.3 vs. 8.6  0.5 mg  
kg
1 min
1)andsuppressionofEGP(69vs.941%),andherbaselineandinsulin-stimulated
ATP synthesis were reduced (7.3 and 8.9 vs. 10.6  1.0 and 12.8  1.3 mol   l
1   min
1)
compared with those of the control subjects. HCLs and IMCLs were comparable between the
MELAS patient and control subjects.
CONCLUSIONS — Impairmentofmusclemitochondrialﬁtnesspromotesinsulinresistance
and could thereby contribute to the development of diabetes in some patients with the MELAS
syndrome.
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T
he MELAS (myopathy, encephalop-
athy, lactic acidosis, and stroke-like
episodes) syndrome is caused by a
maternally inherited mtDNA mutation,
resulting in defective cellular respiration.
MELAS-associated diabetes has been
primarilyattributedtoinsufﬁcientinsu-
lin secretion due to mitochondrial dys-
function of pancreatic -cells. Insulin-
resistant populations show reduced
mitochondrial function and increased so-
leusmusclelipids(intramyocellularlipids
[IMCLs]) and liver lipids (hepatocellular
lipids [HCLs]) (1). The sequence of
events,particularlythepossibilityofmus-
cle mitochondria leading to insulin resis-
tance, is unclear.
RESEARCH DESIGN AND
METHODS— One female patient
(age 37 years, BMI 24 kg/m
2, A1C 7.4%)
suffering from MELAS (mtDNA mutation
A3243G, 60% heteroplasmy in leuko-
cytes, conﬁrmed by PCR ampliﬁcation)
was compared with six nondiabetic fe-
male control subjects (age 45  4 years,
BMI241kg/m
2,A1C5.20.1%).The
protocolwasapprovedbyaninstitutional
ethics board, and written informed con-
sent was obtained. The patient developed
bilateral labyrinthine hypacusis and insu-
lin-dependent diabetes at 26 years of age,
underwent surgery for ptosis, and
showed vascular lesions in her periven-
tricular white matter.
Whole-body insulin sensitivity (insu-
lin-mediatedglucosedisposal,M)anden-
dogenousglucoseproduction(EGP)were
assessed during a normoglycemic-
hyperinsulinemic clamp with infusion of
insulin (40 mU   m body surface area
1  
min
1)(Actrapid;NovoNordisk,Copen-
hagen, Denmark) and 20% dextrose con-
taining 2%-enriched D-[6,6-
2H2]glucose
(2).
Plasma glucose was measured by the
glucose oxidase method (Glucose ana-
lyzerII;BeckmanCoulter,Brea,CA).Free
fatty acid (FFA) was measured microﬂuo-
rimetrically (Wako Chemicals, Rich-
mond, VA). Insulin was measured by
radioimmunoassay (2).
Open-air spirometry (MasterScreen
CPX; Jaeger Viasys Healthcare, Hoech-
berg, Germany) was combined with
continuous heart rate recording (Sport-
testerPE4000; Polar Electro, Oulu, Fin-
land). Resting energy expenditure (REE)
was assessed using the Weir equation:
REE  [3.9(VO2)  1.1(VCO2)]1.44.
Exercise testing was performed on an
electronically braked cycle ergometer
(Lode-Excalibur Sport, Groningen, the
Netherlands).
31P/
1H magnetic resonance spectros-
copy (MRS) was performed at baseline
andrepeatedbetween120and240minof
theclamptoassessﬂuxthroughATPsyn-
thase (fATPase) in gastrocnemius muscle
with saturation transfer experiment (3-T
spectrometer; Bruker, Ettlingen, Ger-
many) (2). Glucose-6-phosphate (G-6-P)
and inorganic phosphate (Pi) were mea-
sured from the ratio of integrated respec-
tivepeakintensitiesand-ATPresonance
intensity (2). Localized
31P-MRS was per-
formed to assess PCr recovery using
STEAM (the stimulated echo acquisition
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AMARES (advanced method for accurate,
robust, and efﬁcient spectral ﬁtting of
MRS data). Aerobic plantar ﬂexion exer-
cise was performed at 50% maximal con-
traction until fatigue. PCr amplitudes
were ﬁtted to a mono-exponential curve
usingnonlinearleastsquares.Ectopiclip-
ids were measured with
1H-MRS (2). The
patient’sPCrrecoverywascomparedwith
that of healthy male subjects from a pre-
viousstudyofours(3),andREEwascom-
pared with the value predicted by the
Harris-Benedict equation for women:
(665.1  9.6  weight)  (1.8 
height)(4.7age).Allothertestswere
performed on the patient and six control
subjects, and data are shown as means 
SEM.
RESULTS
Glucose and FFA metabolism
The MELAS patient had normal fasting
EGP (1.7 vs. 1.7  0.1 mg   kg
1  
min
1), plasma FFA (385 mol/l), and
insulin suppression of lipolysis (95%) in
comparison with the control subjects.
EGPsuppression(69vs.941%)andM
(4.3vs.8.60.5mg kg
1 min
1)were
markedly lower in the patient than in the
control subjects (Fig. 1A).
Energy expenditure
The patient’s respiratory quotient was
0.88, indicating reliance on glucose oxi-
dationduringfasting.REEwaslowerthan
predicted (1,108 vs. 1,355 kcal/24 h).
Maximal power (88 W) and VO2max (19.4
mg   kg
1   min
1) were reduced.
Intracellular metabolites and ATP
synthesis
G-6-P did not increase after insulin stim-
ulation, proving impaired muscle glucose
transport/phosphorylation (control:
75% vs. baseline, P 	 0.001) (Fig. 1B).
Fasting and insulin-stimulated fATPase
werelowerintheMELASpatient(7.3and
8.9mol l
1 min
1)thaninthecontrol
subjects (10.6  1.0 vs. 12.8  1.3 mol  
l
1   min
1, P 	 0.05) (Fig. 1C). The
patient performed plantar ﬂexion for 6.4
min, resulting in 60% PCr depletion,
demonstrating exhaustive exercising.
Postexercise PCr recovery was twice
(6617s)thatofhealthyvolunteers(3),
indicating compromised mitochondrial
ﬁtness (4). Resting ATP concentration
(4.7 mmol/l) and PCr-to-Pi ratio (5.0)
were reduced by 40% compared with
those in healthy volunteers studied under
identical conditions (5). HCLs, albeit
within the normal range (	5%) (6), were
higher in the MELAS patient than in the
control subjects, whereas IMCLs were
similar (Fig. 1D).
CONCLUSIONS — The MELAS pa-
tient exhibited severe reductions in ATP
concentrations and synthesis at baseline,
afterexercise,andduringinsulinstimula-
tion. This was paralleled by muscular and
hepatic insulin resistance. While the
cause of insulin resistance could likely
be explained by primary defects of mi-
tochondrial number and ﬁtness, both
abnormalities could also result from li-
potoxicity. Lipotoxicity can cause not
only-celldysfunctionbutalsomuscular
insulin resistance via inﬂammatory path-
ways, decreasing fat oxidation and raising
IMCLs (7). Normal fasting and insulin
suppression of FFA as well as low IMCLs
wouldargueagainsttheoperationoflipo-
toxicity in our patient. However, her se-
vere hepatic insulin resistance and higher
HCLs are in line with the contention that
hepatic signals, e.g., release of lipids (6),
contributed to muscular insulin resis-
tance and mitochondrial dysfunction. Fi-
nally, despite good long-term metabolic
control, chronic hyperglycemia could have
aggravated insulin resistance and mito-
chondrial dysfunction via glucotoxicity.
Similar to most MELAS patients, our
patient had normal body mass, mani-
festeddiabetesinearlyadulthood,andre-
quired insulin treatment (8). Although
some studies found that patients with mi-
tochondrial diabetes are insulin resistant
(8), others reported normal insulin sensi-
tivity, suggesting that the A3243G muta-
tion in skeletal muscle does not play a
causative role in diabetes development
(9). As the majority of studies show that
MELAS patients present with impaired
glucose-stimulated insulin secretion, oc-
currence of diabetes has been attributed
to impaired -cell function, which
strongly depends on intact mitochondrial
metabolism (7). Our patient presented
with severe insulin resistance, impaired
insulin-stimulated glucose transport/
phosphorylation, reduction of myocellu-
lar concentrations, and synthetic ﬂux of
ATP. These alterations are similar to ﬁnd-
ings in insulin-resistant populations (el-
derly, obese nondiabetic humans, and
ﬁrst-degree relatives of patients with type
2 diabetes) who are at increased risk of
diabetes (10,11). Previous reports found
Figure 1—Whole body insulin sensitivity (M value) (A), glucose phosphorylation/transport
(IMCL G-6-P) (B), and IMCL ATP synthesis as well as ectopic lipids in skeletal muscle (IMCL,
lower portion of the columns) (C) and liver (HCL, total columns) (D) in a female patient with
MELAS syndrome ( ) compared with matched control subjects (CON, o, n  6). f, Insulin-
stimulated increases in G-6-P and ATP synthesis.
ATP synthesis in MELAS
678 DIABETES CARE, VOLUME 32, NUMBER 4, APRIL 2009increased prevalence of A3243G in pa-
tients with type 2 diabetes (12). Thus,
insulin resistance along with lower mus-
cularmitochondrialﬁtnesscouldcontrib-
ute to the manifestation of diabetes in
MELAS patients.
In conclusion, impairment of muscle
mitochondrial ﬁtness contributes to insu-
lin resistance in our patient with MELAS
and diabetes, which resembles the mech-
anism described for ﬁrst-degree relatives
of type 2 diabetic patients. However,
given the broad spectrum of MELAS de-
fectsandheterogeneityofinsulinsensitiv-
ity in these patients, the present report
does not permit the conclusion that
MELAS is a typical model for the patho-
genesis of type 2 diabetes.
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